News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Bright Giant GmbH and Agilent Technologies Announce Collaboration: Innovation for Identification
Wednesday, August 17, 2022Bright Giant GmbH and Agilent Technologies are excited to announce their new product development collaboration designed to enhance nontargeted metabolomics workflows using AIbased methods and empower scientists to make novel impactful discoveries Thi...
AGAE's Pilot Plants Prove Rhamnolipid Production Breakthroughs
Wednesday, August 17, 2022AGAE Technologies LLC AGAE a specialty chemical and biotech company based in Corvallis Oregon USA is proud to announce that it is successfully operating the first fermentation and mass purification pilot plants in North America dedicated to producing...
EpiAxis Therapeutics & Peptilogics Enter Strategic Drug Discovery Partnership
Tuesday, August 16, 2022EpiAxis Therapeutics a leading epigenetics company with a focus on the treatment diagnosis and monitoring of cancer and the prevention of its recurrence and Peptilogics a biotech company engineering peptide therapeutics by combining computation and b...
QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency
Tuesday, August 16, 2022QIAGEN NV announced the launch of the QIAstatDx Viral Vesicular Panel RUO the first syndromic test to differentiate between monkeypox and five other pathogens which cause similar symptoms The new panel currently for research use only RUO comes in c...
WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology
Friday, August 12, 2022WuXi Advanced Therapies a wholly owned subsidiary of WuXi AppTec today announced a licensing agreement with Janssen Biotech Inc one of the Janssen Pharmaceutical Companies of Johnson Johnson Janssen Under this agreement WuXi ATU will license to Jans...
BridgeBio Pharma, Sentynl Therapeutics and Medison Pharma Announce Approval in Israel for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A
Thursday, August 11, 2022BridgeBio Pharma Inc a commercialstage biopharmaceutical company that focuses on genetic diseases and cancers and Sentynl Therapeutics Inc Sentynl a USbased biopharmaceutical company focused on bringing innovative therapies to patients living with ra...
MaaT Pharma Announces Update on U.S. FDA Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease
Thursday, August 11, 2022MaaT Pharma a French clinicalstage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM MET dedicated to improving survival outcomes for patients with cancer today announced that it received a communication from the US Food an...
Ferring Announces U.S. FDA Advisory Committee Meeting for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic
Wednesday, August 10, 2022Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee VRBPAC of the US Food and Drug Administration FDA will hold a meeting on September to review data supporting the biologics license applicat...
Genomind Completes Integration with Epic with support from Parkview Physicians Group
Wednesday, August 10, 2022Genomind a provider of genetic testing and population health management solutions for medication management has partnered with Parkview Physicians Group Psychiatry in Fort Wayne Indiana to complete an interface for laboratory orders and results with...
CYTENA Unveils New Generation of B.SIGHT, a Fully Automated Single-Cell Dispenser for Microorganisms
Tuesday, August 09, 2022CYTENA a BICO group company a leading provider of highprecision instruments for handling biological cells has launched a new instrument to streamline singlecell isolation in microbiology research The next generation BSIGHT is taking the companys auto...
